You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

oleclumab

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Ductal Adenocarcinoma Trial in Toronto (Durvalumab, Oleclumab)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Sep 22, 2023

Muscle Invasive Bladder Cancer Trial in Boston (Durvalumab, Oleclumab)

Completed
  • Muscle Invasive Bladder Cancer
  • Boston, Massachusetts
  • +1 more
Sep 8, 2022

Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 Trial

Recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +5 more
  • Durvalumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in United States (AZD4635, Oleclumab, Durvalumab)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Denver, Colorado
  • +8 more
Jan 12, 2023

NSCLC Trial in Worldwide (Durvalumab, Oleclumab, Monalizumab)

Recruiting
  • Non-small Cell Lung Cancer
  • Stuart, Florida
  • +61 more
Dec 19, 2022

NSCLC Trial in Worldwide (Durvalumab, Oleclumab, Monalizumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • San Diego, California
  • +197 more
Oct 11, 2022

Resectable, Early-stage, NSCLC Trial in Worldwide (Durvalumab, Oleclumab, Monalizumab)

Completed
Has Results
  • Resectable
  • +2 more
  • La Jolla, California
  • +17 more
Feb 23, 2022

Metastatic NSCLC (NSCLC) Trial in Worldwide (Durvalumab, Danvatirsen, Oleclumab)

Active, not recruiting
  • Metastatic Non-Small Cell Lung Cancer (NSCLC)
  • Iowa City, Iowa
  • +45 more
Jan 13, 2023